The questions asked by the host is clear proof that
1) pretty much no one knows anything about leronlimab.
2) no one really cares to investigate and learn more.
How NP made it onto the news is beyond me, but I wish there was more.
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-